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Glaucoma is one of the leading causes of bilateral blindness affecting nearly 8 million people worldwide.
Glaucoma is characterized by a progressive loss of retinal ganglion cells (RGCs) and is often associated
with elevated intraocular pressure (IOP). However, patients with normal tension glaucoma (NTG), a subtype
of primary open-angle glaucoma (POAG), develop the disease without IOP elevation. The molecular pathways
leading to the pathology of NTG and POAG are still unclear. Here, we describe the phenotypic characteristics
of transgenic mice overexpressing wild-type (Wt) or mutated optineurin (Optn). Mutations E50K, H486R and
Optn with a deletion of the ﬁrst (amino acids 153–174) or second (amino acids 426–461) leucine zipper were
used for overexpression. After 16 months, histological abnormalities were exclusively observed in the retina
of E50K mutant mice with loss of RGCs and connecting synapses in the peripheral retina leading to a thin-
ning of the nerve ﬁber layer at the optic nerve head at normal IOP. E50K mice also showed massive apoptosis
and degeneration of entire retina, leading to approximately a 28% reduction of the retina thickness. At the
molecular level, introduction of the E50K mutation disrupts the interaction between Optn and Rab8
GTPase, a protein involved in the regulation of vesicle transport from Golgi to plasma membrane. Wt Optn
and an active GTP-bound form of Rab8 complex were localized at the Golgi complex. These data suggest
that alternation of the Optn sequence can initiate signiﬁcant retinal degeneration in mice.
INTRODUCTION
Glaucoma is characterized by progressive loss of retinal
ganglion cells (RGCs), degeneration of axons in the optic
nerve and visual ﬁeld defects. Primary open-angle glaucoma
(POAG) is one of the major causes of irreversible blind-
ness leading to vision loss in about 4.5 million people and
accounting for 12% of global blindness (1,2). POAG is often
associated with elevated intraocular pressure (IOP), which is
one of main risk factors in glaucoma. However, degenerative
changes in the RGC and the optic nerve head leading to pro-
gressive visual ﬁeld loss may occur even in the absence of
elevated IOP in a subtype of POAG called normal tension
glaucoma (NTG). A recent epidemiological study in Tajimi,
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nosed as NTG (3).
At least 24 different genetic loci have been linked to various
forms of glaucoma, and four glaucoma-associated genes, myo-
cilin, cytochrome P4501B1, OPTN and WD repeat domain 36
(WDR36) have been previously identiﬁed (4–7). A signiﬁ-
cantly higher frequency of OPTN sequence alternations in
glaucoma subjects compared with controls supports the contri-
bution of this gene to the development of glaucoma (8–10). In
one original report, .16.7% of NTG families had mutations in
the OPTN gene (6), and a number of disease-causing amino
acid substitutions including E50K, H486R and R545Q have
been conﬁrmed by others (8–10). The substitution of glutamic
acid by lysine at amino acid 50 (E50K) is exclusively associ-
ated with familial and sporadic forms of NTG (6,8,11). We
also identiﬁed E50K mutation in an NTG family in Japan
(Supplementary Material 1). Several lines of evidence
support E50K mutation could play a critical role for the sever-
ity of phenotype and pathology of glaucoma. Clinical study
revealed that an NTG phenotype is more severe in subjects
with the E50K mutation than in a control group of subjects
with NTG but without this mutation, supporting a critical
role for this mutation (8,12). In vitro cell biological study
demonstrated that transfection of E50K-mutated optineurin
(Optn) caused cell death of rat RGC cell line, RGC5 (13).
OPTN corresponds to the GLC1E locus for adult-onset
POAG and is located in the 10p14 region. The OPTN gene
contains 3 non-coding exons followed by 13 exons encoding
a 577 amino acid protein. Almost all of the reported disease-
causing mutations correspond to positions that are evolutiona-
rily conserved between the mouse, monkey and human. OPTN
is ubiquitously expressed in all tissues and interacts with
number of proteins including huntingtin (14), transcription
factor IIIA (15), Rab8 (16,17), myosin VI (18), FOS (19),
ring ﬁnger protein 11 (20) and metabotrophic glutamate recep-
tor 1-a (21), suggesting multiple cellular functions. Recent
studies have shown that the OPTN promoter is induced by
TNF-a (22). OPTN may function as an adaptor which regu-
lates the assembly of TAX1BP1 and the post-translationally
modiﬁed form of Tax1, leading to a sustained NF-kB acti-
vation (23).
The molecular pathways leading to glaucoma from a single
gene mutation still remain unclear mainly due to (i) insufﬁ-
ciency of clinical and genetic information from glaucoma
patients, (ii) difﬁculty in obtaining clinical material, such as
optic nerve tissues, from patients and (iii) lack of animal
models with particular gene mutations. Recently, it has been
reported that glutamate transporter-deﬁcient mice exhibit an
NTG-like phenotype (24). However, to this date, no animal
models have been produced based on the gene mutation
found in NTG patients.
In this paper, we developed ﬁve variants of Optn overex-
pressing mice including the wild-type (Wt), E50K and
H486R point mutants, and mutants with a deletion of the
ﬁrst or second leucine zipper. We used histopathology to
investigate changes in the optic nerve and retina of each
mutant. Using a modiﬁed protein fragment complementation
method, we also investigated the effects of the E50K mutation
on the interaction with OPTN-interacting protein Rab8, which
controls the vesicle transport.
RESULTS
Construction of mouse Optn mutants and characterization
of expression
Five mouse Optn variants were overexpressed under the CMV
early enhancer/chicken beta-actin (CAG) promoter in trans-
genic mice. These variants included Wt Optn, the E50K and
H489R mutants which are mouse equivalents of the human
glaucoma-causing mutations E50K and H486R, respectively,
and mutants with deletion of the ﬁrst (1st LZ del) or second
(2nd LZ del) Optn leucine zipper domain. All transgenic
mice were born at normal Mendelian ratios, weighed the
same as non-transgenic littermates and appeared normal up
to 16 months of age. The mutant HA-tagged proteins were
ubiquitously expressed in the entire retina (Fig. 1B). The
copy numbers for each mutant cDNA construct were approxi-
mately 12 to 14 per mouse as determined by TaqMan real-time
PCR assay (data not shown).
Comparison of histological changes in the eye of Wt and
mutant Optn transgenic mice
Loss of RGCs and cupping of the optic disc are the deﬁning
histological features of the retina of patients with POAG and
NTG. Therefore, we examined the eyes of aged Wt, E50K,
H489R, 1st LZ del and 2nd LZ del mice using histology and
immunohistochemistry. Cornea, lens and anterior segment of
Wt and transgenic mice were histologically normal even in
16-month-old mice. For statistical analysis, measurements of
retinal thickness were made at the peripheral retina  1.0–
1.2 mm from the optic nerve head. Remarkably, we found sig-
niﬁcant phenotypical changes in ﬁve independent transgenic
mouse lines expressing the E50K mutant (Fig. 2A). The
retinal thickness of E50K mice was signiﬁcantly reduced com-
pared with Wt mice at 16 months of age (∗P , 0.05) (Fig. 2B),
but a reduction of the retinal thickness was observed as early
as 12 months of age (Fig. 2C). Owing to the loss of RGCs and
their axons in the peripheral retina, b-III tubulin-stained nerve
ﬁber layer was relatively thinner at the optic nerve head of
E50K mice compared with Wt mice (Fig. 2D). The
anti-SMI32 immunostaining of the whole-mounted retina
demonstrated loss of large RGCs in the peripheral retina
(Fig. 2D). Progressive, non-speciﬁc loss of RGCs in E50K
mice was shown by counting NeuN-stained cells in the
entire retina sections (Fig. 2D).
To determine which retinal cell types are vulnerable to the
E50K mutation, we performed immunohistochemical analysis
using retinal cell-speciﬁc markers. Immunostaining with calre-
tinin antibodies was used to visualize synapses of RGCs and
amacrine cells in the inner plexiform layer of 16-month-old
Wt and E50K mice (Fig. 3A). Although there was no differ-
ence in the immunolabeling pattern of synapses in the
central retina of Wt and E50K mice (Box C∗∗), a signiﬁcant
degeneration of synapses was observed in the peripheral
retina of E50K mice versus Wt mice (Box P∗∗). Immunolabel-
ing of the ﬂat mount retina using antibodies against choline
acetyltransferase (ChAT, cholinergic amacrine) revealed
areas of amacrine cell loss in the peripheral retina (Box P∗∗)
(Fig. 3B, arrow). Loss and/or changes of another type of ama-
crine cells and rod bipolar cells in the peripheral retina of
Human Molecular Genetics, 2010, Vol. 19, No. 13 2607E50K mice versus Wt were detected by staining with anti-
bodies against tyrosine hydroxylase (red, doperminergic ama-
crine cell) and PKC a (green, rod bipolar cell) (Fig. 3C, Box
P∗∗). The outer plexiform layer (OPL) and outer nuclear layer
(ONL) were also affected in E50K mice. In the OPL,
expression of synaptophysin, synaptic vesicle marker at the
photoreceptor synaptic terminal, was reduced in E50K mice
compared with Wt mice (Fig. 4), whereas rhodopsin-labeled
outer segments were shorter in E50K mutant than in Wt mice.
Apoptosis assay by single-stranded DNA
immunohistochemistry
RGC death by apoptosis is one of the typical features of glau-
coma pathogenesis. Immunostaining with antibodies against
single-stranded DNA (ssDNA), a marker of apoptosis-
associated DNA damage, was used to detect apoptotic
changes in the retina of E50K mice. ssDNA-positive (apopto-
tic) cells were detected not only in the RGCL (Fig. 4A, Arrow)
but also in the INL and ONL. At the peripheral retina, signiﬁ-
cant increase of apoptotic cell number in all retinal layers was
observed in E50K mice at 16 months of age (Fig. 4B) com-
pared with age-matched Wt mice (∗∗P , 0.01).
IOP of Wt and mutant Optn transgenic mice
IOP measurement is a necessary and important step to deter-
mine whether retinal degeneration in our transgenic mice is
associated with the elevation of IOP or it is IOP independent.
IOP was measured using an impact-rebound tonometer and an
optical interferometry tonometer. The average IOP reading
from both devices gave similar IOP for mutant and Wt mice
in the normal range of 15+1 mmHg for all examined ages
(Fig. 5). These results demonstrated that pathological features
of E50K mice are not due to changes in IOP.
E50k mutation disrupts OPTN–Rab8 direct protein
interaction
Protein–protein interaction of OPTN and Rab8 was analyzed
after transfection of RGC5 or COS1 cells with constructs
encoding OPTN (Wt, E50K), Rab8 [Wt, T22N (inactive
GDP form) and Q67L (active GTP form)] tagged with ﬂuor-
escent labels (Fig. 6A). We observed .4-fold decrease in
the interaction between OPTN Wt and the active form
(Q67L) versus the inactive form (T22N) of Rab8. However,
E50K did not interact with either form of Rab8 in RGC5
cells (Fig. 6B). Interaction of Wt OPTN and the active form
Rab8 was further supported by co-localization of the
complex with a speciﬁc Golgi marker, GM130, in COS1
cells (Fig. 6C).
DISCUSSION
In the present study, we produced and characterized the phe-
notype of ﬁve different transgenic Optn mice lines including
lines with overexpression of two OPTN mutations identiﬁed
in glaucoma patients. Among the 15 OPTN mutations pre-
viously identiﬁed (P16A, H26D, E50K, K66R, E92V,
E103D, 2 bp insertion between amino acids 127–128,
V161M, H228Y, A336G, A377T, I407T, A466S, H486R
and R545Q), we selected two mutations E50K and H486R,
which has been conﬁrmed by several groups to be associated
with severe NTG and/or juvenile open-angle glaucoma
Figure 1. (A) Schematic diagram of the mouse Optn constructs used in this study. Positions of mutations and deletions are shown in lower boxes. Predicted
binding sites of Optn-interacting proteins are shown in upper boxes. (B) Expression of Optn mutants in the retina of transgenic mice. Sections were immunos-
tained with anti-HA antibody. Scale bar: 20 mm.
2608 Human Molecular Genetics, 2010, Vol. 19, No. 13(JOAG) (6,8–11,25–27). E50K, a substitution of glutamic
acid by lysine at amino acid 50, is exclusively associated
with the familial and sporadic forms of NTG (6,8,11), and
that phenotype is, on an average, more severe compared
with NTG without the E50K mutation (Supplementary
Material) (6). A study by Hauser et al.( 12) also reported a
more severe glaucomatous phenotype in a patient with E50K
mutation than that in the other NTG patient. The H486R
mutation is reportedly associated with both NTG and JOAG
(4,26). Histidine 486 is an evolutionarily conserved residue
located at the C-terminus, where ﬁve other proteins, adeno-
virus E3-14.K, huntingtin, metabotrophic glutamate receptor
1-a, myosin VI, ring ﬁnger protein 11, can interact with
Optn (Fig. 1A). On the other hand, we chose 1st and 2nd
LZ del as the transgenic construct design. As shown in
Figure 1A, both LZ regions are binding sites for various func-
tional molecules—1st LZ: Rab8 and FOS; 2nd LZ: Hunting-
tin, E3-14.7K, Myosin6, mGluR1, RNF11. To elucidate the
functional defect which may occur by deleting these regions,
we generated 1st and 2nd LZ del transgenic mice.
Figure 2. Comparison of retina morphology of normal, Wt and mutant transgenic mice. (A) HE staining of retina sections of 16-month-old normal and transgenic
mice. Scale bar: 200 mm (upper panel), 50 mm (lower panel). (B) Quantiﬁcation of the retina thickness measurements of different transgenic lines at 16 months of
age. Six retina samples were measured in each group. Signiﬁcant thinning of the retina was observed only for E50K mice (∗P , 0.05). (C) Quantiﬁcation of the
retina thickness measurements of E50K mice of different ages (6 to 16 months; n ¼ 6 for each time point). E50K mice showed statistically signiﬁcant retinal
thinning at 16 months of age. (D) Tubulin b-III immunostaining of the Wt and E50K mice at the optic nerve head (scale bar: 50 mm). Reduction of the RGC
number at the peripheral retina is shown by NeuN immunostaining of parafﬁn section and SMI32 immunostaining of ﬂat mount retina for Wt and E50K mice
(scale bar: 100 mm). RGCs were counted over entire parafﬁn sections for NeuN immunostaining. Right panel represents quantiﬁcation of these results. Signiﬁ-
cant loss of the RGCs was observed in the E50K mice compared with Wt (∗P , 0.05).
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genic line would show distinct phenotype because of different
locations of mutations, inﬂuencing different OPTN-interacting
proteins. Surprisingly, only E50K mutant showed severe histo-
pathological changes in mice. The E50K mice showed not
only loss of RGCs, but also progressive retinal degeneration
exclusively in the peripheral region (Figs. 2–4). Immunolabel-
ing of ssDNA demonstrated that apoptotic changes occurred in
all retinal cell layers. The number of cells in different retinal
layers, including amacrine, bipolar and photoreceptor cells,
and thickness of all retinal cell layers were reduced in the per-
ipheral retina of E50K mice.
Herein, a question may rise from these ﬁndings in E50K
mice: why is neuronal degeneration eminent at the peripheral
retina, not at the central retina? Previous reports have indi-
cated that mouse models of glaucoma follow similar natural
courses of peripheral retinal degeneration. These include the
well-known glaucoma mouse model, the DBA/2J mouse,
and recently reported GLAST-deﬁcient mouse, where all
layers of the peripheral retina were shown to be affected,
leading to a signiﬁcant reduction of retinal thickness (24,28).
The myocilin Tyr437His transgenic mouse, a POAG mouse
model, also develops RGC loss at the peripheral retina and
retinal degeneration (29,30). These three mouse models all
share a pattern of peripheral degeneration with Optn E50K
mice. In general, glaucoma most often affects peripheral
visual ﬁeld at early stages of the disease, whereas deterioration
of the central retina can be seen only at later stages of the
disease (31). We can speculate that the increased sensitivity
of peripheral RGCs is associated with longer non-myelinated
axons compared with the central RGCs, but this would not
explain the degeneration of other neuronal cells. Further inves-
tigation is required to explain the difference of E50K suscep-
tibility between mouse and human at the peripheral retina. The
fact that E50K mice develop a phenotype of peripheral RGC
degeneration which is similar to the previous glaucoma
mouse models suggests that later stages of cellular and mol-
ecular mechanisms for neuronal degeneration are shared
between NTG and POAG. Therefore, the use of E50K mice
in exploring the mechanisms of NTG pathogenesis, as well
as the development of new therapeutic interventions, holds
great promise.
Rab8 belongs to a family of small GTP-binding proteins
which act as regulators of multiple cellular processes. Rab
GTPases regulate all stages of membrane trafﬁcking, including
vesicle transport, cargo sorting, transport, tethering and fusion
(32). Rab8 has been shown to be involved in polarized mem-
brane transport and regulation of vesicular transport from the
trans-Golgi network (33). Recently, OPTN was demonstrated
to protect survival of NIH3T3 cells under oxidative stress by
relocating to the nucleus in an Rab8-dependent manner,
whereas E50K lost the ability to translocate to the nucleus
(34). These previous functional analyses of the protein–
protein interaction reveal that OPTN–Rab8 complex is
involved in multiple functions that are essential for retinal
and optic nerve health. Thus, alterations of this complex by
E50K mutation may inﬂuence the entire cellular function,
leading to glaucomatous-like pathology.
Our study demonstrated for the ﬁrst time a direct protein–
protein interaction of OPTN and Rab8 at the Golgi-complex
and spreading vesicles (Fig. 6C), which was completely abol-
ished by E50K mutation. The downstream effect of this dis-
ruption can be predicted by two studies by Buss and
colleagues and Canals and colleagues, who demonstrated
the importance of OPTN–Rab8 complex with myosin VI
or huntingtin for post-Golgi trafﬁcking, respectively
(18,35). Sahlendaer et al.( 18) demonstrated that OPTN
and active Rab8 interact with myosin VI and this is essential
for the formation of Golgi ribbon and exocytosis. del Toro
et al.( 35) demonstrated that a mutation in huntingtin
reduces interaction with OPTN–Rab8 complex, resulting in
delocalization of the complex in Golgi and impairment of
post-Golgi trafﬁcking. In both studies, OPTN–Rab8 was
considered essential component of post-Golgi trafﬁcking
system, whereas OPTN served as an effecter protein of
Rab8 and a binding partner of the actin-based motor
protein myosin VI. Disruption of this complex may result
in a signiﬁcant reduction of selected protein transport
within the cell and to the cell surface for secretion. It
would be interesting to investigate what type of cargo is
affected by the E50K mutation and if cells be rescued by
supplementing this cargo molecule. If these proteins can be
Figure 3. Changes in the retina of E50K mice. (A) Immunostaining of the
retina sections with anti-calretinin antibody, a speciﬁc marker for RGCs and
amacrine cells. Disruption of synapses between RGCs and amacrine cells
was observed in the peripheral retina of E50K but not control mice (yellow
box, P∗∗). Scale bar: 20 mm. (B) Immunostaining of the ﬂat mount retina
with ChAT (red) and NeuN (green). A signiﬁcant number of starburst ama-
crine cells were lost in the RGC layer in the peripheral retina of E50K
mutant mice (P∗∗) compared with Wt mice (P∗). Scale bar: 50 mm. (C) Immu-
nostaining of the retina sections with tyrosine hydroxylase (red) and PKC a
(green), speciﬁc markers for dopaminergic amacrine cells and rod bipolar
cells, respectively. Amacrine cell loss and size reduction of bipolar cells
were observed. Scale bar: 20 mm.
2610 Human Molecular Genetics, 2010, Vol. 19, No. 13identiﬁed, it may serve as potential therapeutic approach to
treat glaucoma patients with E50K mutation.
In the photoreceptor, Rab8 has a pivotal role of docking and
fusion in rhodopsin trafﬁcking (36) and cooperating with
Bardet–Biedl syndrome proteins in ciliary membrane biogen-
esis (37,38). One possible explanation about the signiﬁcant
apoptotic changes in the ONL suggests that disruption of
OPTN–Rab8 complex may affect the trafﬁcking not only in
the RGCs but also in the photoreceptors. Until now, there
are no reports about the correlation between OPTN and
Rab8 in the photoreceptors, or OPTN-mutated glaucoma and
photoreceptor function. Considering trafﬁcking malfunction
via OPTN mutation as the etiology of glaucoma, E50K mice
provides a good animal model to explore the pathogenesis of
RGC and photoreceptor.
MATERIALS AND METHODS
Cloning of mouse Optn and site-directed mutagenesis
Total RNA was extracted from a fresh C57BL/6N mouse brain
tissue using TRIzol (Invitrogen, Carlsbad, CA, USA) and
reverse-transcribed into ﬁrst-strand cDNA using oligo-dT
adaptor primer and SuperScript First-Strand Synthesis System
for RT–PCR (Invitrogen). OPTN cDNA was ampliﬁed by
PCR using oligonucleotides 5′-cggaattccgatgtcccatcaacctctgag-3′
and 5′-cggaattccgtcaaatgatgcagtccatca-3′ as primers. The
ampliﬁed DNA fragment was puriﬁed using a MinElute gel
extraction kit (Qiagen, Hilden, Germany), ligated into pBlue-
script II (KS-) (Agilent Technologies, Santa Clara, CA, USA)
and sequenced using the M13 primers and ABI PRISM 3130
(Applied Biosystems, Foster City, CA, USA). Site-directed
Figure 4. Degeneration of the OPL and ONL in the peripheral retina of E50K mice. (A) Immunostaining of the retina sections with synaptophysin, rhodopsin and
ssDNA, speciﬁc markers for neuronal presynaptic vesicles, rod photoreceptors and apoptosis cells, respectively. Synapse disruption (arrow), rod photoreceptor
cells degeneration and apoptosis cells were observed in the OPL and/or ONL in the peripheral retina of E50K mice. Scale bar: 20 mm. (B) Percentage of apop-
totic cells in the ONL (n ¼ 6, ∗∗P , 0.01).
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the deletion of the E50K mutation, the ﬁrst leucine zipper (1st
LZ del), deletion of the second leucine zipper (2nd LZ del)
and the H489R mutation. The following primers were used:
5′-cagctcaaactcaactccgg-3′ and 5′-atgctccacttcctgctcca-3′ for
1st LZ del, 5′-aaatgaaggaactcctggttaagaaccaccagctgaaagaa-3′
and 5′-ttctttcagctggtggttcttaaccaggagttccttcattt-3′ for E50K,
5′-gagaccatggccgtcctc-3′ and 5′-caacatcttgtccaccttttctg-3′ for
2 n dL Zd e la n d5 ′-gcagcaagagagaagattcgtgaagaaaaggagcagc-3′
and 5′-gctgctccttttcttcacgaatcttctctcttgctgc-3′ for H489R. Plas-
mids were digested with EcoRI, puriﬁed by agarose gel electro-
phoresis and recovered using the MinElute gel extraction kit
according to the manufacturer’s protocol. The cDNA inserts
were ligated into EcoRI-digested pCMVHA vector (Takara
Bio USA, Madison, WI, USA). HA-tagged Optns were ampli-
ﬁed by PCR using oligonucleotides 5′-ccgctcgagcgccaccatgatg
tacccatacgatgttcc-3′ and 5′-ccgctcgagcggtcaaatgatgcagtccatca-3′
as primers. HA-tag was inserted at the N-terminus of Optn
constructs for the detection of proteins expressed by the trans-
gene. The ampliﬁed DNA fragments were puriﬁed using a
MinElute gel extraction kit (Qiagen), ligated into the
expression vector and sequenced as described earlier.
Development of transgenic mice overexpressing mutant
Optn
The expression vector pCAGGS containing chicken beta-actin
promoter with CMV enhancer kindly provided by Dr Junichi
Miyazaki of Osaka University was used for strong ubiquitous
expression of the transgene in mice. cDNA inserts were
released from the pCAGGS vector using SalI and BamHI.
These restriction fragments were injected into pronuclear-
stage BDF1/C57BL6N embryos, and transgenic mice were
generated at PhoenixBio Co., Ltd (Tochigi, Japan). Offspring
were screened for the transgene by isolating genomic DNA
from tail biopsies followed by PCR. Primers used for PCR
were 5′-ctctagagcctctgctaaccatgt-3′ and 5′-ccatggccataagagcg
taa-3′. To determine copy number of transgenes, real-time
PCR was performed using TaqMan MGB probe (Applied Bio-
systems), according to manufacturer’s standard protocols.
Primers and probe for the mouse beta-actin were 5′-AGGC
CAACCGTGAAAAGATG-3′ (forward), 5′-TGAGAAGCTG
GCCAAAGAGAA-3′ (reverse) and 5′-CCCAGGTCAGTAT
CC-3′ (probe); for the CAG promoter were 5′-CCGCAGCC
ATTGCCTTT-3′ (forward), 5′-TTCGGCTCCGCACAGATT-3′
(reverse) and 5′-CGCAGGGACTTCC-3′ (probe). To deter-
mine the absolute amount of the copy number of beta-actin,
PCR products of mouse beta-actin ampliﬁed from genomic
DNA were cloned into the pCAGGS vector. The copy
number of beta-actin gene in mouse genome was measured
with real-time PCR analyses, the puriﬁed plasmid DNAs
were used as standards. To determine the transgene copy
number, multiplex quantitative PCR was performed for both
CAG promoter as a target and beta-actin gene as a reference.
All experiments with mice were performed in accordance with
the Association for Research in Vision and Ophthalmology
Statement for the Use of Animals in Vision Research.
Histology and immunohistochemistry
Mice were sacriﬁced with Nembutal (150 mg/kg) i.p., and the
eyes were removed quickly. For histology, mouse eyes were
dissected and immersed in Davidson’s solution ﬁxative over-
night at 48C. The eyes were embedded in parafﬁn and sec-
tioned at 5 mm thickness along the vertical meridian through
the optic nerve head. After deparafﬁnization and rehydration,
sections were stained with hematoxylin and eosin (HE) stain-
ing. Images of HE staining were collected with Nikon Eclipse
light microscope (Nikon, Tokyo, Japan).
For immunohistochemistry, after deparafﬁnization and rehy-
dration, eye sections were treated with Target Retrieval Solution
(DakoCytomation, Denmark). These sections were incubated
Figure 5. IOP measurement of Wt and E50K mice. IOP was measured using
an impact-rebound tonometer and an optical interferometry tonometer
between 9 AM and noon in 4-month and 16-month-old mice. Both methods
gave similar results (IOP of 15+1 mmHg) for Wt and transgenic mice at
both ages examined (n ¼ 6).
2612 Human Molecular Genetics, 2010, Vol. 19, No. 13with blocking solution for 1 h followed by overnight incubation
with primary antibody against HA tag (1:500 dilution;
Sigma-Aldrich, St Louis, MO, USA), OPTN (1:500 dilution;
kindgiftfromDrMansoorSarfarazi,UniversityofConnecticut),
tubulin b-III isoform (1:100 dilution; Millipore, Billerica, MA,
USA), NeuN (1:100 dilution; Millipore), calretinin (1:500
dilution; Sigma), tyrosine hydroxylase (1:100 dilution; Milli-
pore), PKC a (1:500 dilution; Millipore), rhodopsin (1:200
dilution; Santa Cruz, CA, USA), synaptophysin (1:500 dilution;
Abcam, Cambridge, MA, USA) or ssDNA (1:500 dilution;
Immuno-Biological Laboratories, Gunma, Japan) in phosphate-
buffered saline (PBS) containing 1% BSA at 48C. Slides were
washed in PBS and then incubated with Alexa 488 or Alexa
568 (1:500 dilution; Invitrogen)-conjugated anti-mouse or
rabbit IgG and 4′,6′-diamidino-2-phenylindole (DAPI) for
nuclear staining for 1 h at room temperature. The stained
tissues were examined using confocal ﬂuorescence laser micro-
scope (Radiance 2000, Bio-Rad Laboratories, Hercules, CA,
USA). Control slides were processed similarly, except for the
omission of primary antibodies (data not shown).
Figure 6. Disruption of OPTN–Rab8 interaction by the E50K mutation. (A) A diagram of cDNA constructs used in experiments to study protein–protein inter-
action. (B) The protein–protein interaction of OPTN Wt and E50K with Rab8 T22N (GDP inactive form), and Q67L (GTP active form) was measured in RGC-5
cells as described in Materials and Methods. Interaction of OPTN Wt and Q67L-active form of Rab8 was increased ﬁve times over Rab8 T22N-inactive form of
Rab8 protein (∗∗P , 0.01). E50K did not show any interaction with any construct including the active form of Rab8 (n ¼ 6). (C) Co-localization of the OPTN–
Rab8 complex (green) and Golgi marker GM130 (red). COS1 cells were transfected with constructs encoding indicated constructs and stained with antibodies
against GM130 48 h after transfection as described in Materials and Methods. Nuclei (blue) were stained with DAPI.
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The whole-mount immunostaining was performed essentially as
described (39,40). Brieﬂy, neural retinas were separated from
the posterior eyes, ﬁxed in 4% PFA/PBS for 2 h on ice and
incubated with the anti-SMI32 (1:200 dilution; Sternberger
Monoclonals, Baltimore, MD, USA), anti-ChAT (1:100
dilution; Millipore) or anti-active NeuN (1:250 dilution; Milli-
p o r e )a n t i b o d yf o r7d a y sa t4 8C. Slides were washed in PBS
containing 0.1% Triton X-100 and then incubated with Alexa
488 or Alexa 568 (1:500 dilution; Invitrogen)-conjugated anti-
m o u s eo rr a b b i tI g G / D A P If o r2d a y sa t4 8C. Whole-mounted
retinal samples were placed on slides, with the vitreous facing
up. Radial cuts were made in the peripheral retina, and the
retinal tissue was ﬂattened with a ﬁne brush. The retinas were
then mounted with Vectashield (Vector Laboratories, Burlin-
game, CA, USA) and evaluated with a confocal microscope.
Measurement of IOP
The average IOP for each genotype was recorded. IOP was
measured using an impact-rebound tonometer (Colonal
Medical Supply, Franconia, NH, USA) and optical interfero-
metry tonometer (FISO Technologies, Quebec, Canada) for
mice of each genotype as described (29). Using the rebound
tonometer, we were able to measure IOP in awake and non-
sedated mice of various ages, whereas optical interferometry
tonometry was performed on anesthetized animals. Measure-
ment of IOP was always performed in the morning between
10 and 12 AM. The mice successfully assessed for each gen-
otype and age were 18 weeks and 16 months.
Measurement of OPTN–Rab8 interaction
OPTN–Rab8 interaction analysis was performed using Coral-
Hue
w Fluo-chase Kit (MBL, Tokyo, Japan). Based on the
instruction manual, we constructed OPTN Wt, E50K, Rab8
Q67L (GTP-bound active form), Rab8 T22N (GDP-bound inac-
tive form), with ﬂuorescence tag protein (mKG_N or mKG_C)
on either N-terminal or C-terminal (Fig. 6A). RGC-5 and COS1
cells were transfected by each pair of the plasmid mixtures
using Fugene HD (Roche Diagnostics, Mannheim, Germany).
Forty-eight hours after transfection, the medium was replaced
to PBS and the cells were observed with inverted microscope
(Eclipse TE300, Nikon). To observe localization of OPTN–
Rab8 complex, cells were ﬁxed 48 h after transfection with
4% paraformaldehyde in PBS on ice for 20 min. Cells were
incubated in blocking buffer (3% bovine serum albumin,
0.1% Triton X-100 in PBS) and then with anti-GM130 antibody
(BD Bioscience, San Jose, CA, USA) at room temperature for
1 h each. Cells were washed three times with PBS-T (0.1%
Triton X-100 in PBS) and incubated with Alexa-568-conjugated
secondary antibody for 1 h at room temperature. Slides were
washed, mounted and analyzed by confocal microscopy.
Statistical analysis
All data were expressed as the mean+standard deviation.
Statistical differences were analyzed by the ANOVA or Stu-
dent’s t-test. ∗P , 0.05 was considered statistically signiﬁcant.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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